NC
CVS icon

Nicholas Company’s CVS Health CVS Stock Holding History

Nicholas Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59,700
Closed -$3.75M – 216
2024
Q3 		$3.75M Sell
59,700
-12,495
-17% -$729K 0.06% 209
2024
Q2 		$4.26M Sell
72,195
-27,750
-28% -$1.74M 0.07% 199
2024
Q1 		$7.97M Hold
99,945
– – 0.13% 150
2023
Q4 		$7.89M Buy
99,945
+8,840
+10% +$629K 0.14% 137
2023
Q3 		$6.36M Sell
91,105
-390
-0.4% -$27.6K 0.13% 161
2023
Q2 		$6.33M Hold
91,495
– – 0.12% 168
2023
Q1 		$6.8M Hold
91,495
– – 0.14% 159
2022
Q4 		$8.53M Hold
91,495
– – 0.18% 129
2022
Q3 		$8.73M Buy
91,495
+60
+0.1% +$5.94K 0.2% 116
2022
Q2 		$8.47M Sell
91,435
-200
-0.2% -$19.5K 0.19% 126
2022
Q1 		$9.27M Sell
91,635
-700
-0.8% -$73.5K 0.17% 138
2021
Q4 		$9.53M Hold
92,335
– – 0.16% 143
2021
Q3 		$7.84M Hold
92,335
– – 0.14% 165
2021
Q2 		$7.7M Hold
92,335
– – 0.14% 175
2021
Q1 		$6.95M Sell
92,335
-3,500
-4% -$255K 0.13% 192
2020
Q4 		$6.55M Sell
95,835
-630
-0.7% -$41K 0.12% 185
2020
Q3 		$5.63M Buy
96,465
+23,565
+32% +$1.47M 0.12% 175
2020
Q2 		$4.74M Buy
72,900
+15,000
+26% +$945K 0.11% 182
2020
Q1 		$3.44M Buy
57,900
+30,205
+109% +$2.02M 0.1% 185
2019
Q4 		$2.06M Buy
+27,695
New +$1.94M 0.04% 209
2014
Q4 		– Sell
-692
Closed -$55K – 238
2014
Q3 		$55K Hold
692
– – ﹤0.01% 236
2014
Q2 		$52K Hold
692
– – ﹤0.01% 238
2014
Q1 		$51K Sell
692
-500
-42% -$35.3K ﹤0.01% 239
2013
Q4 		$85K Hold
1,192
– – ﹤0.01% 245
2013
Q3 		$67K Hold
1,192
– – ﹤0.01% 248
2013
Q2 		$68K Buy
+1,192
New +$69.1K ﹤0.01% 254

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Nicholas Company's CVS Position: Q4 2024 in Review

Nicholas Company sold out of CVS Health (CVS) in Q4 2024, closing a stake of 59,700 shares — an estimated $3.75M sold.

Nicholas Company first reported a position in CVS in Q2 2013 and held it in 26 quarters. The position peaked at $9.53M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Nicholas Company reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Nicholas Company sold 59,700 CVS Health shares in Q4 2024, an estimated $3.75M.
  • Nicholas Company first reported a position in CVS Health in Q2 2013 and held it in 26 quarters.
  • Nicholas Company's CVS Health position peaked at $9.53M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Nicholas Company's 13F filing for Q4 2024, filed 10 Feb 2025.